25.01.2022 - Sandusky, OH, Jan. 25, 2022 (GLOBE NEWSWIRE) - PAO Group, Inc. (OTC Pink: PAOG) today cited recently published information on research indicating CBDA and CBGA, compounds found in hemp, “block a critical step in the process the [Covid] virus uses .
06.01.2022 - Sandusky, OH, Jan. 06, 2022 (GLOBE NEWSWIRE) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed the development of a line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) is underway. PURA has updated its business model over .
PAOG CBD Nutraceuticals Underdevelopment To Be Distributed Through USMJ
News provided by
Share this article
Share this article
SANDUSKY, Ohio, Jan. 27, 2021 /PRNewswire/ PAO Group, Inc. (USOTC: PAOG) today announced moving forward with its initiative to produce cannabis nutraceuticals. PAOG added that the nutraceuticals, in addition to other distribution channels, will be available through the North American Cannabis, Inc. (
USOTC: USMJ) ecommerce site www.usjm.com.
PAOG recently engaged with the Puerto Rico Consortium for Clinical Investigation (PRCCI) to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical product to provide care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD).